A STUDY TO EVALUATE THE EFFECTIVENESS OF VIRECHANA KARMA AND PUNARNAVADI NIRUHA BASTI ALONG WITH SHAMANA CHIKITSA IN STAGE I AND STAGE II CHRONIC KIDNEY DISEASE

J S AYURVED MAHAVIDYALAYA0 个研究点目标入组 20 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients fulfilling the diagnostic criteria.
•2. Patients having age between 18 to 65 years of both gender will be included for the study.
•3. Patients having serum creatinine level less than 3.0 mg/dl.
•4. Patients indicated for Virechana and Basti.

•1. Female patients having pregnancy, breast feeding or post-delivery period.
•2. Patients of end stage renal disease
•3. Patients who are on dialysis treatment from more than 1 month period. Patients who are already operated for renal transplantation and then having nephropathy.
•4. Patients of hepato-renal insufficiency or renal insufficiency due to haemodynemic circulatory disorders and CCF.
•5. Patients with some serious illness like cardio-vascular diseases, psychological disorders, serious acute organic diseases, serious chronic co-morbidities, hypo or hyper thyroidism, liver or metabolic disorders etc.
•6. Patients on renal replacement therapy.
•7. Patients with bleeding piles or any other bleeding disorders.
•8. Patients contraindicated for Virechana and Basti.

发起方

J S AYURVED MAHAVIDYALAYA